Electronic Filing Packs Bigger Charge For Supplement AERs Than 3500A Changes
This article was originally published in The Tan Sheet
Executive Summary
FDA proposes modifications to form 3500A “to enhance the clarity and utility of the information collected,” but the form continues to be more conducive for compiling information on adverse event reported for OTC and Rx drugs than for supplement products.